[go: up one dir, main page]

HK1042412B - 含七碳脂肪酸甘油三酯的營養補充劑或藥物製劑 - Google Patents

含七碳脂肪酸甘油三酯的營養補充劑或藥物製劑

Info

Publication number
HK1042412B
HK1042412B HK02102246.6A HK02102246A HK1042412B HK 1042412 B HK1042412 B HK 1042412B HK 02102246 A HK02102246 A HK 02102246A HK 1042412 B HK1042412 B HK 1042412B
Authority
HK
Hong Kong
Prior art keywords
fatty acid
nutritional supplement
carbon fatty
triglycerides
pharmaceutical preparation
Prior art date
Application number
HK02102246.6A
Other languages
English (en)
Other versions
HK1042412A1 (en
Inventor
R Roe Charles
Original Assignee
Baylor Res Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor Res Institute filed Critical Baylor Res Institute
Publication of HK1042412A1 publication Critical patent/HK1042412A1/xx
Publication of HK1042412B publication Critical patent/HK1042412B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
HK02102246.6A 1999-02-05 2002-03-25 含七碳脂肪酸甘油三酯的營養補充劑或藥物製劑 HK1042412B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11903899P 1999-02-05 1999-02-05
PCT/US2000/003022 WO2000045649A1 (en) 1999-02-05 2000-02-03 Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid

Publications (2)

Publication Number Publication Date
HK1042412A1 HK1042412A1 (en) 2002-08-16
HK1042412B true HK1042412B (zh) 2006-01-06

Family

ID=22382253

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02102246.6A HK1042412B (zh) 1999-02-05 2002-03-25 含七碳脂肪酸甘油三酯的營養補充劑或藥物製劑

Country Status (14)

Country Link
EP (1) EP1150579B1 (zh)
JP (2) JP4902906B2 (zh)
KR (1) KR100702823B1 (zh)
CN (2) CN100408031C (zh)
AT (1) ATE303079T1 (zh)
AU (1) AU775708C (zh)
CA (1) CA2361070C (zh)
DE (1) DE60022312T2 (zh)
HK (1) HK1042412B (zh)
HU (1) HUP0200511A3 (zh)
IL (1) IL144645A0 (zh)
MX (1) MXPA01007988A (zh)
NZ (1) NZ513329A (zh)
WO (1) WO2000045649A1 (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003160486A (ja) * 2001-09-17 2003-06-03 Lion Corp 経口養育毛剤及び該養育毛剤を含有する飲食品
JPWO2004022050A1 (ja) * 2002-09-05 2005-12-22 日清オイリオグループ株式会社 脂質代謝調整剤および飲食物
AU2003261926A1 (en) * 2002-09-05 2004-03-29 The Nisshin Oillio Group, Ltd. Slimming agents and foods and drinks comprising the same
AU2003261927A1 (en) * 2002-09-05 2004-03-29 The Nisshin Oillio Group, Ltd. Peroxisome proliferator-activated receptor controllers
WO2006014353A2 (en) * 2004-07-02 2006-02-09 Baylor Research Institute Glycogen or polysaccharide storage disease treatment method
EP1929995A1 (en) * 2006-12-04 2008-06-11 INSERM (Institut National de la Santé et de la Recherche Médicale) Anaplerotic therapy of Huntington disease and other polyglutamine diseases
DE102008057867A1 (de) * 2008-11-18 2010-05-20 B. Braun Melsungen Ag Fettemulsion zur künstlichen Ernährung von schwerkranken Intensivpatienten
JP2013528648A (ja) * 2010-06-14 2013-07-11 ベイラー リサーチ インスティテュート 成人ポリグルコサン小体病（ａｐｂｄ）を処置するためのトリヘプタノイン食
GB201210699D0 (en) * 2012-06-15 2012-08-01 Vitaflo Ltd Nutritional food
CA2894456C (en) 2012-12-13 2022-06-28 Baylor Research Institute Triheptanoin for the treatment of glucose transporter 1 deficiency
EP3068492B1 (en) 2013-11-14 2020-01-08 The University of Queensland Neurodegenerative disorders and methods of treatment and diagnosis thereof
KR102291310B1 (ko) * 2013-11-14 2021-08-23 울트라제닉스 파마수티컬 인코포레이티드 트리글리세리드의 고체 조성물 및 이의 용도
WO2017079721A1 (en) 2015-11-06 2017-05-11 The Children's Hospital Of Philadelphia Compositions and methods for the treatment of fatty acid metabolism disorders
US11844775B2 (en) 2018-07-11 2023-12-19 University of Pittsburgh—of the Commonwealth System of Higher Education Method of treating fatty acid oxidation disorders using Omega3/Omega6 unsaturated or branched chain fatty acids

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5215834A (en) * 1975-07-12 1977-02-05 Ajinomoto Kk Method of producing food composition
CA1302280C (en) * 1986-04-21 1992-06-02 Jon Joseph Kabara Topical antimicrobial pharmaceutical compositions and methods
US5153221A (en) * 1990-10-05 1992-10-06 Elena Avram Method for the treatment of acquired immune deficiency syndrome
US5569675A (en) * 1994-03-07 1996-10-29 Bar Ilan University Methods of using carboxylic acid esters to increase fetal-hemoglobin levels
DE4439947A1 (de) * 1994-11-09 1996-05-15 Boehringer Mannheim Gmbh 2,2-Dichloralkancarbonsäuren, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
ATE257712T1 (de) * 1996-08-27 2004-01-15 Hemosol Inc Gesteigerte stimulation der erythropoesis
US5908631A (en) * 1997-02-27 1999-06-01 L'oreal S.A. Monohydric alcohol-free composition for topical use comprising solubilized ethylcellulose

Also Published As

Publication number Publication date
JP5553815B2 (ja) 2014-07-16
MXPA01007988A (es) 2003-07-14
HUP0200511A3 (en) 2003-03-28
AU775708B2 (en) 2004-08-12
DE60022312D1 (de) 2005-10-06
JP2002536304A (ja) 2002-10-29
ATE303079T1 (de) 2005-09-15
HK1042412A1 (en) 2002-08-16
WO2000045649A1 (en) 2000-08-10
CN100408031C (zh) 2008-08-06
EP1150579A1 (en) 2001-11-07
KR100702823B1 (ko) 2007-04-06
CA2361070C (en) 2012-04-17
CA2361070A1 (en) 2000-08-10
JP4902906B2 (ja) 2012-03-21
AU3223600A (en) 2000-08-25
IL144645A0 (en) 2002-05-23
CN1345188A (zh) 2002-04-17
NZ513329A (en) 2003-11-28
HUP0200511A2 (en) 2002-06-29
JP2012082202A (ja) 2012-04-26
AU775708C (en) 2005-07-14
EP1150579B1 (en) 2005-08-31
KR20010108173A (ko) 2001-12-07
CN101574335A (zh) 2009-11-11
DE60022312T2 (de) 2006-07-06

Similar Documents

Publication Publication Date Title
HK1042412A1 (en) Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven carbon fatty acid
Jensen The composition of bovine milk lipids: January 1995 to December 2000
ZA200004725B (en) Process for the fermentative preparation of D-pantothenic acid using coryneform bacteria.
HK1020316A1 (en) Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid
CA2191645A1 (en) Pharmaceutical composition comprising l-carnitine or an alkanoyl l-carnitine in combination with a polyunsaturated fatty acid of the omega-3 series for the prevention and the treatment of lipid metabolism disorders
ATE257701T1 (de) Diätzusammensetzung zur steigerung des metabolismus und zur linderung von oxydativem stress
NZ516101A (en) Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents
HK1058883A1 (en) Use of coenzyme q (ubiquinone) and eicosapentaenoic acid (epa) for the treatment of non-hodgkin's lymphoma and psychiatric or neurological disorders.
JP2002531116A5 (zh)
WO2004103307A3 (en) Method of use of five and fifteen carbon fatty acids
AU6843000A (en) High lipid diet
CA2004332A1 (en) Inhibition of cell adhesion
AU554413B2 (en) Linoleic acid and essential fatty acid compositions as
SG162836A1 (en) Use of a combination comprising l-carnitine or alkanoyl l-carnitine, lipid solubl benzoquinone and omega-3-polyunsaturated fatty acid for the preparation of a dietary supplement or medicament for the treatment of corneal diseases
CN201207848Y (zh) 一种宠物笼
Lin et al. Arabinogalactan present in the mountain celery seed extract potentiated hypolipidemic bioactivity of coexisting polyphenols in hamsters
CA2386790A1 (en) Chromium-histidine complexes as nutrient supplements
CA2162042A1 (en) Enteral Nutritional Product
McGinnis Oxidative stress in autism
EP1129711A3 (en) Pinolenic acid against diabetes
MY110206A (en) Substituted mandelic acid derivaties,processes for their preparation and their use in medicaments
AU783660C (en) Lactic acid bacteria transformed to be provided with respiratory metabolism, and ferments comprising said lactic acid bacteria
CN205493038U (zh) 一种麻将桌
CN205268480U (zh) 一种心内科诊疗床
CN202077875U (zh) 一种可移动的视听电视展示柜

Legal Events

Date Code Title Description
CHRG Changes in the register

Free format text: FROM BAYLOR UNIVERSITY MEDICAL CENTER ? ???????? TO BAYLOR RESEARCH INSTITUTE ??

PE Patent expired

Effective date: 20200202